Literature DB >> 19793928

Development and validation of GFR-estimating equations using diabetes, transplant and weight.

Lesley A Stevens1, Christopher H Schmid, Yaping L Zhang, Josef Coresh, Jane Manzi, Richard Landis, Omran Bakoush, Gabriel Contreras, Saul Genuth, Goran B Klintmalm, Emilio Poggio, Peter Rossing, Andrew D Rule, Matthew R Weir, John Kusek, Tom Greene, Andrew S Levey.   

Abstract

BACKGROUND: We have reported a new equation (CKD-EPI equation) that reduces bias and improves accuracy for GFR estimation compared to the MDRD study equation while using the same four basic predictor variables: creatinine, age, sex and race. Here, we describe the development and validation of this equation as well as other equations that incorporate diabetes, transplant and weight as additional predictor variables.
METHODS: Linear regression was used to relate log-measured GFR (mGFR) to sex, race, diabetes, transplant, weight, various transformations of creatinine and age with and without interactions. Equations were developed in a pooled database of 10 studies [2/3 (N = 5504) for development and 1/3 (N = 2750) for internal validation], and final model selection occurred in 16 additional studies [external validation (N = 3896)].
RESULTS: The mean mGFR was 68, 67 and 68 ml/min/ 1.73 m(2) in the development, internal validation and external validation datasets, respectively. In external validation, an equation that included a linear age term and spline terms in creatinine to account for a reduction in the magnitude of the slope at low serum creatinine values exhibited the best performance (bias = 2.5, RMSE = 0.250) among models using the four basic predictor variables. Addition of terms for diabetes and transplant did not improve performance. Equations with weight showed a small improvement in the subgroup with BMI <20 kg/m(2).
CONCLUSIONS: The CKD-EPI equation, based on creatinine, age, sex and race, has been validated and is more accurate than the MDRD study equation. The addition of weight, diabetes and transplant does not significantly improve equation performance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793928      PMCID: PMC2910328          DOI: 10.1093/ndt/gfp510

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  35 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Invited commentary: body composition in studies of aging: new opportunities to better understand health risks associated with weight.

Authors:  Tamara B Harris
Journal:  Am J Epidemiol       Date:  2002-07-15       Impact factor: 4.897

3.  Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.

Authors:  Peter Jacobsen; Steen Andersen; Kasper Rossing; Berit R Jensen; Hans-Henrik Parving
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

4.  Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.

Authors:  J Lewis; L Agodoa; D Cheek; T Greene; J Middleton; D O'Connor; A Ojo; R Phillips; M Sika; J Wright
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

5.  Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy.

Authors:  Peter Jacobsen; Steen Andersen; Kasper Rossing; Birgitte V Hansen; Hans-Henrik Parving
Journal:  Nephrol Dial Transplant       Date:  2002-06       Impact factor: 5.992

6.  Weight stability masks sarcopenia in elderly men and women.

Authors:  D Gallagher; E Ruts; M Visser; S Heshka; R N Baumgartner; J Wang; R N Pierson; F X Pi-Sunyer; S B Heymsfield
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-08       Impact factor: 4.310

7.  Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.

Authors:  Peter Rossing; Philip Hougaard; Hans-Henrik Parving
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

8.  The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants.

Authors:  Michael Mauer; Keith Drummond
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

9.  Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy.

Authors:  Henrik Post Hansen; Ellis Tauber-Lassen; Berit R Jensen; Hans-Henrik Parving
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

10.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

View more
  43 in total

1.  Discrepancy Between Equations Estimating Kidney Function in Geriatric Care: A Study of Implications for Drug Prescription.

Authors:  Florent Guerville; Claire Roubaud-Baudron; Sophie Duc; Nathalie Salles; Muriel Rainfray; Isabelle Bourdel-Marchasson
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

2.  The Chronic Kidney Disease Epidemiology Collaboration equation improves the detection of hyperfiltration in Chinese diabetic patients.

Authors:  Fangya Zhao; Lei Zhang; Junxi Lu; Kaifeng Guo; Mian Wu; Haoyong Yu; Mingliang Zhang; Yuqian Bao; Haibing Chen; Weiping Jia
Journal:  Int J Clin Exp Med       Date:  2015-12-15

3.  Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions.

Authors:  Andrew S Levey; Lesley A Stevens
Journal:  Am J Kidney Dis       Date:  2010-04       Impact factor: 8.860

Review 4.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

Review 5.  The applicability of eGFR equations to different populations.

Authors:  Pierre Delanaye; Christophe Mariat
Journal:  Nat Rev Nephrol       Date:  2013-07-16       Impact factor: 28.314

6.  Obesity increases the risk of end-stage renal disease among living kidney donors.

Authors:  Jayme E Locke; Rhiannon D Reed; Allan Massie; Paul A MacLennan; Deirdre Sawinski; Vineeta Kumar; Shikha Mehta; Roslyn B Mannon; Robert Gaston; Cora E Lewis; Dorry L Segev
Journal:  Kidney Int       Date:  2016-12-29       Impact factor: 10.612

7.  Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations.

Authors:  Kazunori Murata; Nikola A Baumann; Amy K Saenger; Timothy S Larson; Andrew D Rule; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

8.  The effectiveness of long-term agalsidase alfa therapy in the treatment of Fabry nephropathy.

Authors:  Sandro Feriozzi; Joan Torras; Markus Cybulla; Kathy Nicholls; Gere Sunder-Plassmann; Michael West
Journal:  Clin J Am Soc Nephrol       Date:  2012-01       Impact factor: 8.237

9.  Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?

Authors:  Youssef Bennis; Amandine Savry; Magali Rocca; Laurence Gauthier-Villano; Pascale Pisano; Bertrand Pourroy
Journal:  Int J Clin Pharm       Date:  2014-01-17

10.  Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study.

Authors:  Nawar M Shara; Hong Wang; Mihriye Mete; Yaman Rai Al-Balha; Nameer Azalddin; Elisa T Lee; Nora Franceschini; Stacey E Jolly; Barbara V Howard; Jason G Umans
Journal:  Am J Kidney Dis       Date:  2012-07-25       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.